Skip to main content
Clinical Trials/CTRI/2024/04/065482
CTRI/2024/04/065482
Not yet recruiting
Phase 4

A randomised controlled trial comparing the total dose of Benzodiazepines with Dexmedetomidine as an adjunct to Benzodiazepine versus standard Benzodiazepine therapy for achieving arousable sedation in patients with Severe alcohol withdrawal. - NI

Pradeep S0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: F101- Alcohol abuse
Sponsor
Pradeep S
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Pradeep S

Eligibility Criteria

Inclusion Criteria

  • Patients with severe alcohol withdrawal(F10\.231\) as defined BY ICD\-10 guidelines

Exclusion Criteria

  • Patient under 18 years of age,pregnant women,patients with limited life expectancy due to chronic diseases,patients with pre existing neurological illness,Concomitant Substance abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials